Effects of β-Adrenergic Antagonists on the QT Measurements from Exercise Stress Tests in Pediatric Patients with Long QT Syndrome

Pediatric Cardiology

Volumn 24, Issue 6, 2003, Pages 553-558

  Kaltman, J R ^a   Ro, P S ^b   Stephens, P ^a   McBride, M G ^a   Cohen, M I ^c   Tanel R E , ^a   Vetter, V L ^a   Rhodes, L A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Arizona Pediatric Cardiology Consultants   (United States)

Author keywords

Adrenergic antagonists; Long QT syndrome; QT dispersion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE; NADOLOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART PROTECTION; HUMAN; INFUSION; LONG QT SYNDROME; MALE; PEDIATRICS; QT INTERVAL; STATISTICAL SIGNIFICANCE; SUPINE POSITION;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; STATISTICS, NONPARAMETRIC;

EID: 0344010716     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-003-0436-0     Document Type: Article

References (22)

1. Bazett H (1918) An analysis of the time relations of electrocardiograms. Heart 7:353-370
2. Day C, McComb J, Campbell R (1990) QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63:342-344
3. Fridericia L (1920) Die systolendauer im elektrokardiogramm bei normalen menchen und bei herzkranken. Acta Med Scand 53:469-486
4. Garson A, Dick M, Fournier A, et al. (1993) The long QT syndrome in children: an international study of 287 patients. Circulation 87:1866-1872
5. Hii JT, Wyse DG, Gillis AM, et al. (1992) Precordial QT dispersion as a marker of torsades de pointes. Disparate effects of class la antiarrhythmic drugs and amiodarone. Circulation 86:1376-1382
6. Hodges M, Salerno D, Erlien D (1983) Bazett's QT correction reviewed. Evidence that a linear QT correction for heart rate is better [Abstract]. J Am Coll Cardiol 1:694
7. Linker NJ, Colonna P, Kekwick CA, et al. (1992) Assessment of QT dispersion in symptomatic patients with congenital long QT syndrome. Am J Cardiol 69:634-638
8. Locati E, Schwartz P (1992) The idiopathic long QT syndrome: therapeutic management. PACE 15:1374-1379
9. Moss AJ, Zareba W, Hall WJ, et al. (2000) Effectiveness and limitations of β-blocker therapy in congenital long QT syndrome. Circulation 101:616-623
10. Paridon S (1998) Exercise testing. In: Garson A, Bricker J, Fisher D, Neish S (Eds.), The Science and Practice of Pediatric Cardiology. Williams & Wilkins, Baltimore, pp 875-888
11. Priori SG, Napolitano C, Diehl L, Schwartz PJ (1994) Dispersion of the QT interval: a marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 89:1681-1689
12. Sagie A, Larson M, Goldberg R, Bengston J, Levy D (1992) An improved method for adjusting the QT interval for heart rate (The Framingham Heart Study). Am J Cardiol 70:797-801
13. Schwartz PJ, Priori SG, Spazzolini C, et al. (2001) Genotype-phenotype correlation in the long QT syndrome: gene-specific triggers for life threatening arrhythmias. Circulation 103:89-95
14. Shimizu W, Antzelevitch C (1998) Cellular basis for the ECG features of the LQT1 form of the long QT syndrome: effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsades de pointes. Circulation 98:2314-2322
15. Shimizu W, Antzelevitch C (2000) Differential effects of β-adrenergic agonists and antagonists in LQT1, LQT2, and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35:778-786
16. Shimizu W, Kamakura S, Kurita T, et al. (1997) Influence of epinephrine, propanolol, and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome. J Cardiovasc Electrophysiol 8:1102-1114
17. Shimizu W, Ohe T, Kurita T, et al. (1995) Effects of verapamil and propanolol on early after depolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 26:1299-1309
18. Silka M, Garson A (1999) Ventricular arrhythmias. In: Gillette P, Garson A (Eds.), Clinical Pediatric Arrhythmias. Saunders, Philadelphia, p 133
19. Stramba-Badiale M, Goulene K, Schwartz P (1997) Effects of β-adrenergic blockade on dispersion of ventricular repolarization in newborn infants with prolonged QT interval. Am Heart J 134:406-410
20. Sun Z, Swan H, Vitasalo M, Toivonen L (1998) Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome. J Am Coll Cardiol 31:1400-1405
21. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC, Wellens HJ (1995) Reproducible induction of early afterdepolarizations and torsades de pointes arrhythmia by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 91:864-872
22. Wilde AA, Jongbloed RJ, Doevendans PA, et al. (1999) Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol 33:327-332